Literature DB >> 21414826

Polymorphisms in FADS1 and FADS2 alter desaturase activity in young Caucasian and Asian adults.

Diana M Merino1, Holly Johnston, Shannon Clarke, Kaitlin Roke, Daiva Nielsen, Alaa Badawi, Ahmed El-Sohemy, David W L Ma, David M Mutch.   

Abstract

Recent evidence indicates that genetic variation in fatty acid desaturases 1 and 2 (FADS1 and FADS2) is associated with changes in plasma fatty acid profiles; however, the association with altered desaturase activity has not been examined in different ethnic populations. The present study examined whether genetic variation in the FADS gene cluster regulates desaturase activity in two populations of young Canadian adults (Caucasian and Asian) and whether altered desaturase activity was reflected in both n-3 and n-6 fatty acid profiles. FADS1 and FADS2 were genotyped in a random subset of participants (Caucasian, n=78; Asian, n=69) from the Toronto Nutrigenomics and Health study using MALDI-TOF mass spectrometry, and plasma fatty acids were measured by gas chromatography. Desaturase activities were estimated using the following fatty acid ratios: γ-linoleic acid to linoleic acid (GLA:LA), arachidonic acid to linoleic acid (AA:LA), arachidonic acid to dihomo-γ-linoleic acid (AA:DGLA), and eicosapentaneoic acid to α-linolenic acid (EPA:ALA). Nineteen single nucleotide polymorphisms (SNPs) were examined, and several SNPs (9 in Caucasians and 8 in Asians) were associated with various desaturase activities. The most significant association detected was between the FADS1 rs174547 SNP and AA:LA in both Caucasians (p=4.0 × 10(-8)) and Asians (p=5.0 × 10(-5)). Although the minor allele for this SNP differed between Caucasians (T) and Asians (C), carriers of the C allele had a lower desaturase activity than carriers of the T allele in both groups. To determine whether rs174547 was a dominant SNP in the FADS gene cluster, we constructed an additional model which included this SNP as a covariate. Only one SNP (rs498793 in FADS2) remained associated with the EPA:ALA ratio (p=1.1 × 10(-5)) in Asians. This study shows that genetic variation in the FADS gene cluster (in particular rs174547) can alter desaturase activity in subjects of Caucasians and Asian descent.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21414826     DOI: 10.1016/j.ymgme.2011.02.012

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  48 in total

Review 1.  Polyunsaturated fatty acid metabolism in prostate cancer.

Authors:  Isabelle M Berquin; Iris J Edwards; Steven J Kridel; Yong Q Chen
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Plasma levels of 14:0, 16:0, 16:1n-7, and 20:3n-6 are positively associated, but 18:0 and 18:2n-6 are inversely associated with markers of inflammation in young healthy adults.

Authors:  Maude Perreault; Kaitlin Roke; Alaa Badawi; Daiva E Nielsen; Salma A Abdelmagid; Ahmed El-Sohemy; David W L Ma; David M Mutch
Journal:  Lipids       Date:  2013-12-15       Impact factor: 1.880

3.  Genetic variation at the FADS1-FADS2 gene locus influences delta-5 desaturase activity and LC-PUFA proportions after fish oil supplement.

Authors:  Maryam Al-Hilal; Aseel Alsaleh; Zoitsa Maniou; Fiona J Lewis; Wendy L Hall; Thomas A B Sanders; Sandra D O'Dell
Journal:  J Lipid Res       Date:  2012-11-15       Impact factor: 5.922

4.  Can polymorphisms in the fatty acid desaturase (FADS) gene cluster alter the effects of fish oil supplementation on plasma and erythrocyte fatty acid profiles? An exploratory study.

Authors:  Suzanne J Meldrum; Yuchun Li; Guicheng Zhang; Alexandra E M Heaton; Nina D'Vaz; Judith Manz; Eva Reischl; Berthold V Koletzko; Susan L Prescott; Karen Simmer
Journal:  Eur J Nutr       Date:  2017-09-19       Impact factor: 5.614

5.  Docosahexaenoic acid (DHA) supplementation in pregnancy differentially modulates arachidonic acid and DHA status across FADS genotypes in pregnancy.

Authors:  S A Scholtz; E H Kerling; D J Shaddy; S Li; J M Thodosoff; J Colombo; S E Carlson
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2014-11-07       Impact factor: 4.006

6.  Joint effects of fatty acid desaturase 1 polymorphisms and dietary polyunsaturated fatty acid intake on circulating fatty acid proportions.

Authors:  Juan Juan; Hongyan Huang; Xia Jiang; Andres V Ardisson Korat; Mingyang Song; Qi Sun; Walter C Willett; Majken K Jensen; Peter Kraft
Journal:  Am J Clin Nutr       Date:  2018-05-01       Impact factor: 7.045

7.  Insertion-deletions in a FADS2 intron 1 conserved regulatory locus control expression of fatty acid desaturases 1 and 2 and modulate response to simvastatin.

Authors:  Holly T Reardon; Jimmy Zhang; Kumar S D Kothapalli; Andrea J Kim; Woo Jung Park; J Thomas Brenna
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-06-27       Impact factor: 4.006

8.  Fatty acid metabolism: Implications for diet, genetic variation, and disease.

Authors:  Janel Suburu; Zhennan Gu; Haiqin Chen; Wei Chen; Hao Zhang; Yong Q Chen
Journal:  Food Biosci       Date:  2013-12-01       Impact factor: 4.240

9.  FADS2 genotype regulates delta-6 desaturase activity and inflammation in human adipose tissue.

Authors:  Maija Vaittinen; Paula Walle; Emmi Kuosmanen; Ville Männistö; Pirjo Käkelä; Jyrki Ågren; Ursula Schwab; Jussi Pihlajamäki
Journal:  J Lipid Res       Date:  2015-11-25       Impact factor: 5.922

10.  Genome-wide association study of plasma N6 polyunsaturated fatty acids within the cohorts for heart and aging research in genomic epidemiology consortium.

Authors:  Weihua Guan; Brian T Steffen; Rozenn N Lemaitre; Jason H Y Wu; Toshiko Tanaka; Ani Manichaikul; Millennia Foy; Luigi Ferrucci; Myriam Fornage; Dariush Mozafarrian; Michael Y Tsai; Lyn M Steffen; Stephen S Rich; Lu Wang; Jennifer A Nettleton; Weihong Tang; Xiangjun Gu; Stafania Bandinelli; Irena B King; Barbara McKnight; Bruce M Psaty; David Siscovick; Luc Djousse; Yii-Der Ida Chen
Journal:  Circ Cardiovasc Genet       Date:  2014-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.